Since anemia is a frequent comorbidity found in ESRD and dialysis patients [26], key elements were targeted by AI software [26]: erythropoietin-stimulating agents [27], hemoglobin target [28], and iron treatment dosing [29]. This evidence concerns the gene EPO and anemia (phenotype).